BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2014
View Archived Issues
Phase I study of Cellceutix's Prurisol meets primary endpoint
Read More
Cancer Research UK and Cancer Research Technology join forces with Astellas Pharma
Read More
Tufts Medical Center and ATON Partners form neurological-focused company CereVasc
Read More
Cellectar Biosciences files IND to evaluate I-131-CLR-1404
Read More
First patients enrolled in phase II trial of photofrin PDT for mesothelioma
Read More
Biodel reports phase IIa data for BIOD-531 in patients with type 2 diabetes
Read More
Sanofi and MannKind enter into global licensing agreement for Afrezza
Read More
Optimization of RORc inverse agonists from Genentech
Read More
Topline results from first pivotal study of Rayaldee for secondary hyperparathyroidism
Read More
BMS-986118, a novel potent dual-acting GPR40 agonist for the treatment of diabetes
Read More
PDE10A inhibitors for the treatment of schizophrenia
Read More
Human Longevity and Celgene Cellular Therapeutics sign agreement for PSC-100
Read More
Salix Pharmaceuticals reports topline data from TARGET 3 trial
Read More
Development of a rapid point-of-care diagnostic test EBOV and SUDV detection
Read More
Investigators from Emory University disclose Cas9 gene therapy
Read More
Japan investigators report development of hLAT1 inhibitors
Read More
Bristol-Myers Squibb discloses new NS5B inhibitors
Read More
In vivo results demonstrate high potential of FR-104 for clinical transplantation
Read More
Step-wise optimization of an anticancer MAb for maximum inhibitory effect
Read More
CureDuchenne supports Prosensa's efforts to advance DMD pipeline
Read More
Oncothyreon to use Alpine's protocell technology for delivery of molecular therapeutics
Read More
FDA grants orphan drug designation to OncoSynergy's OS-2966 for glioblastoma
Read More
Amarantus Bioscience collaborates with the Buck Institute for Research on Aging
Read More
Venaxis updates on progress of appendicitis risk test in U.S.
Read More
Celltrion files for FDA approval of infliximab biosimilar
Read More
Cempra initiates phase III trial of solithromycin to treat gonorrhea
Read More